| CIMAX | PGDRX | CIMAX / PGDRX | |
| Total Expense Ratio | 0.59 | 1.37 | 43% |
| Annual Report Gross Expense Ratio | 0.59 | 1.37 | 43% |
| Fund Existence | 24 years | 10 years | - |
| Gain YTD | 9.513 | 14.936 | 64% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 140B | 2.44B | 5,742% |
| Annual Yield % from dividends | 3.49 | 2.75 | 127% |
| Returns for 1 year | 8.66 | 14.76 | 59% |
| Returns for 3 years | 27.25 | 19.33 | 141% |
| Returns for 5 years | 31.24 | 21.26 | 147% |
| Returns for 10 years | 75.03 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RAPCX | 11.10 | 0.04 | +0.36% |
| Cohen & Steers Real Assets C | |||
| LAFGX | 17.31 | 0.05 | +0.29% |
| Lord Abbett International Growth F | |||
| TBCUX | 16.42 | 0.02 | +0.12% |
| Tweedy, Browne Intl Val II - Ccy UnH | |||
| SEVIX | 14.75 | N/A | N/A |
| SEI US Managed Volatility I (SIMT) | |||
| JAGLX | 81.02 | -0.20 | -0.25% |
| Janus Henderson Global Life Sciences T | |||